Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Application of quantitative microbiological risk assessment in the field of pharmaceutical environmental monitoring

Pharma Middle East

Mostafa Essam Eissa

HIKMA Pharma, Egypt

Posters-Accepted Abstracts: Clin Pharmacol Biopharm

DOI: 10.4172/2167-065X.C1.014

Abstract
Quantitative Microbiological Risk Assessment (QMRA) is a valuable tool that has been used in the field of food industry and drinking water evaluation. This technique could be applied in the assessment of potential risk that may arise from the contamination of the medicinal products from manufacturing environment including pharmaceutical water on the final consumer. Another simple technique that can be used by the health care professionals was developed by using Quantitative Risk Index (QRI). This index was developed based on combination of factors that contribute to the final microbiological safety level of the drug. As the risk value increases the possibility of hazard delivered to the patient increases. The risk takes into account the infectivity of microorganisms for specific patient condition by certain route, their abundance in environment, manufacturing processes that are hostile to the viability of microbes, antimicrobial power of the product including water activity, the volume or batch size of the dedicated drug, the maximum single dose that can be delivered to the patient and the general trend of microbial count. The newly applied risk showed primarily agreement with QMRA in the ranking of risks that is associated with specific bacteria under study. However, the expanding gap between the continually increasing number of objectionable microbes and the lack of the exact data about infective dose for human by specific route of each objectionable bug is rising and requires an extensive care by healthcare scientists to understand the risk associated with each microorganisms and not only the common pathogens.
Biography

Email: mostafaessameissa@yahoo.com

Top